The Scientist

» FDA

Most Recent

image: Positive Trial Results for Experimental DMD Gene Therapy

Positive Trial Results for Experimental DMD Gene Therapy

By Catherine Offord | June 20, 2018

Preliminary data from Sarepta Therapeutics has exceeded expectations, causing a surge in company stock prices this week.

0 Comments

Biotechs have developed enzyme replacements and genetically modified probiotics to treat patients with the rare metabolic disorder.

0 Comments

image: Congress Passes “Right to Try” Bill

Congress Passes “Right to Try” Bill

By Jim Daley | May 23, 2018

Medical groups have criticized the legislation, which will give terminal patients access to experimental treatments, as dangerous and unnecessary.

0 Comments

image: FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

FDA Approves Drug to Ease Symptoms of Opioid Withdrawal

By Catherine Offord | May 17, 2018

Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.

0 Comments

Two patients became legally blind after receiving treatments at the facilities.

0 Comments

The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.    

3 Comments

Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers.

1 Comment

image: Recipients of Experimental Herpes Vaccine File Lawsuit

Recipients of Experimental Herpes Vaccine File Lawsuit

By Catherine Offord | March 15, 2018

The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.

0 Comments

The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.

0 Comments

image: FDA Report on BPA’s Health Effects Raises Concerns

FDA Report on BPA’s Health Effects Raises Concerns

By Ashley Yeager | February 28, 2018

The pre-peer review assessment finds the compound has “minimal effects,” but endocrinologists and others say key data have yet to come out.

0 Comments

Popular Now

  1. Two University of Rochester Professors Resign in Protest
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Koko the Signing Gorilla Dies at 46